Back to Search Start Over

Effect of a novel herbal vaginal suppository containing myrtle and oak gall in the treatment of vaginitis: a randomized clinical trial.

Authors :
Askari, Sayyede Fatemeh
Jahromi, Bahia Namavar
Dehghanian, Amirreza
Zarei, Afsoon
Tansaz, Mojgan
Badr, Parmis
Azadi, Amir
Mohagheghzadeh, Abdolali
Source :
DARU: Journal of Pharmaceutical Sciences. 9/4/2020, Vol. 28, p603-614. 12p.
Publication Year :
2020

Abstract

Background: Uncomplicated infections such as candidiasis, bacterial vaginosis (BV), or trichomoniasis are easy to diagnose and treat. However, about 8% of patients will have a more complicated course with failure to respond to treatment or rapid recurrence of symptoms. There are many suggestions in Traditional Persian Medicine like myrtle (Myrtus communis L.) and oak gall (Quercus infectoria G.Olivier) for treatment of vaginitis. Objectives: A clinical trial was designed to assess the efficacy of a novel herbal suppository, containing myrtle and oak gall (MOGS) in treatment of vaginitis. Methods: In a parallel randomized clinical trial, 120 women with vaginitis were randomly assigned to MOGS, metronidazole, or placebo. Formulation was simulated from traditional Persian manuscripts and MGOS was prepared after pharmaceutical optimization processing as well as quantification of gallic acid by HPLC. The study was double-blind for MOGS and placebo and single-blind for metronidazole group. Results: MOGS effectively improved vaginal discharge (p = 0.024 for BV and 0.018 for trichomoniasis) and pH (compared to placebo (p = 0.013) and metronidazole (p = 0.001)). Both MOGS and metronidazole could reverse whiff test. Metronidazole was the best medication for making Nugent score negative (p = 0.005) as well as the best therapy according to laboratory findings to treat BV in comparison with placebo (p = 0.021). While for trichomoniasis, MOGS could improve the disease more successfully (p = 0.001). Both MOGS and metronidazole treated mixed vaginitis (p = 0.002). Conclusion: MOGS would be a chance for developing new treatment for trichomoniasis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15608115
Volume :
28
Database :
Academic Search Index
Journal :
DARU: Journal of Pharmaceutical Sciences
Publication Type :
Academic Journal
Accession number :
154196722
Full Text :
https://doi.org/10.1007/s40199-020-00365-6